Clinical Trials Browser

Completed × Peritoneal Neoplasms × Breast × Clear all

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01384253 2016-09-30

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Phase 1 Completed

18 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Phase NA Completed

39 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

Clinical Trials

PIPAC-nabpac

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer